Loading clinical trials...
Loading clinical trials...
Phase I/II Randomized Clinical Trial to Assess the Safety and Feasibility of Transendocardial Injection of Bone Marrow Autologous Mesenchymal Stem Cells in Patients With Idiopathic Dilated Cardiomyopathy.
Conditions
Interventions
bone marrow-derived MSCs injection
placebo intervention
Locations
2
Spain
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
Hospital Clinico Universitario de Valladolid
Valladolid, Valladolid, Spain
Start Date
March 1, 2013
Primary Completion Date
March 1, 2018
Completion Date
March 1, 2018
Last Updated
November 18, 2016
Francisco Fernandez Avilés, MD
CONTACT
Lead Sponsor
Hospital General Universitario Gregorio Marañon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions